The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database
Abstract Background Immunotherapy has paved the way for new therapeutic opportunities in cancer but has failed to show any efficacy in Pancreatic Adenocarcinoma (PDAC), and its therapeutic role remains unclear. The objective of this study is to examine the impact of immunotherapy in combination with...
Main Authors: | Saber Amin, Michael Baine, Jane Meza, Morshed Alam, Chi Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-06-01
|
Series: | Radiation Oncology |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01569-5 |
Similar Items
-
The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who do not receive definitive surgery of the tumor
by: Saber Amin, et al.
Published: (2020-09-01) -
The Association of the Sequence of Immunotherapy With the Survival of Unresectable Pancreatic Adenocarcinoma Patients: A Retrospective Analysis of the National Cancer Database
by: Saber Amin, et al.
Published: (2020-09-01) -
The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis
by: Saber Amin, et al.
Published: (2020-06-01) -
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
by: S. K. Daniel, et al.
Published: (2019-04-01) -
Immunotherapy for pancreatic ductal adenocarcinoma: Challenges and opportunities
by: GE Weiyu, et al.
Published: (2019-05-01)